Back to Search
Start Over
BRAF mutant metastatic colorectal cancers: new arrows in our quiver.
- Source :
-
Annals of translational medicine [Ann Transl Med] 2019 Dec; Vol. 7 (Suppl 8), pp. S367. - Publication Year :
- 2019
-
Abstract
- Competing Interests: Conflicts of Interest: C Cremolini reported receiving personal fees from F. Hoffman-La Roche, Bayer, Sirtex, and Amgen. A Falcone reported receiving grants and personal fees from F. Hoffman-La Roche, Amgen, and Merck Serono as well as personal fees from Celgene, Bayer, and Sanoļ¬ Aventis. The other authors have no conflicts of interest to declare.
Details
- Language :
- English
- ISSN :
- 2305-5839
- Volume :
- 7
- Issue :
- Suppl 8
- Database :
- MEDLINE
- Journal :
- Annals of translational medicine
- Publication Type :
- Editorial & Opinion
- Accession number :
- 32016085
- Full Text :
- https://doi.org/10.21037/atm.2019.08.118